Silence Therapeutics
Yahoo Finance • 9 days ago
Spotlight On Silence Therapeutics And 2 Other Promising Penny Stocks
As February begins, the U.S. stock market is showing strength, with major indexes like the Dow Jones and S&P 500 posting significant gains. In this context of rising indices, investors often look for opportunities that may offer growth pot... Full story
Yahoo Finance • 2 years ago
Silence Therapeutics plc's (NASDAQ:SLN) 65% Price Boost Is Out Of Tune With Revenues
Silence Therapeutics plc (NASDAQ:SLN) shares have had a really impressive month, gaining 65% after a shaky period beforehand. Unfortunately, the gains of the last month did little to right the losses of the last year with the stock still d... Full story
Yahoo Finance • 2 years ago
Silence Therapeutics Announces Positive Topline Results from Phase 1 Multiple Dose Study of Zerlasiran in Subjects with High Lipoprotein(a) and Stable Atherosclerotic Cardiovascular Disease
Zerlasiran showed very significant and durable reductions in lipoprotein(a) of up to 99% Lp(a) levels remained around 90% lower than baseline at study endpoint LONDON, November 01, 2023--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq:... Full story
Yahoo Finance • 3 years ago
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright BioConnect Investor Conference
LONDON, April 25, 2023--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through precisi... Full story
Yahoo Finance • 3 years ago
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates
LONDON, January 12, 2023--(BUSINESS WIRE)--Silence Therapeutics plc, Nasdaq: SLN ("Silence" or "the Company"), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing diseases through preci... Full story
